Vaccine effectiveness of inactivated and mRNA COVID-19 vaccine platform during Delta and Omicron wave in Jakarta, Indonesia: A test-negative case-control study

Vaccine effectiveness of inactivated and mRNA COVID-19 vaccine platform during Delta and Omicron wave in Jakarta, Indonesia: A test-negative case-control study

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Erlina Burhan, Farchan Azzumar, Fira Alyssa Gabriella Sinuraya, Sabarinah Prasetyo, Dwi Gayatri, Iwan Ariawan, Muhammad Ilham Dhiya Rakasiwi, Hanna Lianti Afladhia, Ahmad Fadhil Ilham, Ihya Akbar, Elvan Wiyarta
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12148159/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vaccine effectiveness of inactivated and mRNA COVID-19 vaccine platform during Delta and Omicron wave in Jakarta, Indonesia: A test-negative case-control study.
by: Erlina Burhan, et al.
Published: (2025-01-01)

Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data
by: Erlina Burhan, et al.
Published: (2025-04-01)

Differential White Blood Cell Count and COVID-19 Hospital Length of Stay: A Post-hoc Analysis
by: Gita Fajri Gustya, et al.
Published: (2024-09-01)

Predictive factors of patient length of stay with multiloculated pleural effusion after medical thoracoscopy: single-center retrospective cohort study
by: Wiwien Heru Wiyono, et al.
Published: (2025-07-01)

Depression in Patients with Lung Cancer during the COVID-19 Pandemic
by: Hanna Lianti Afladhia, et al.
Published: (2025-01-01)

The Pandemic is in Progress: Long Covid, Omicrons, Vaccination and Vaccines
by: E. P. Kharchenko
Published: (2022-11-01)

Clinical characteristics and booster vaccine effectiveness of the Omicron variant
by: Lijun Sun, et al.
Published: (2024-11-01)

Differential immunity induced by Omicron sublineages in naïve and vaccine breakthrough infections
by: Noah Brazer, et al.
Published: (2025-07-01)

Effects of vaccination on antibody level and duration of viral shedding in Omicron patients
by: Zhen Wan, et al.
Published: (2024-09-01)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
by: Jianyang Liu, et al.
Published: (2023-12-01)

COVID-19 vaccination coverage in hypertensive patients with Omicron infection: Comments on factors
by: Hinpetch Daungsupawong, et al.
Published: (2023-12-01)

Effect of COVID-19 vaccination coverage on transmission and mortality during Omicron dominance
by: Stephen Chukwuma Ogbodo, et al.
Published: (2025-02-01)

Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai
by: Qianhui Wu, et al.
Published: (2023-12-01)

A Variant of Concern (VOC) Omicron: Characteristics, Transmissibility, and Impact on Vaccine Effectiveness
by: Angel Yun-Kuan Thye, et al.
Published: (2022-10-01)

Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
by: Sibel Kalyoncu, et al.
Published: (2025-01-01)

The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia
by: Eida Nurhadzira Muhammad, et al.
Published: (2025-06-01)

Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022–2023
by: Laura P. Hurley, et al.
Published: (2025-12-01)

Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages
by: Li Guo, et al.
Published: (2023-12-01)

Enhancing COVID-19 vaccination as a public programme in Indonesia
by: Rano K. Sinuraya, et al.
Published: (2025-12-01)

High immunity and low mortality after Omicron and mass event in Cameroon despite low vaccination
by: Yap Boum II, et al.
Published: (2024-11-01)

Evaluation of Vaccine Strategies among Healthcare Workers during COVID-19 Omicron Outbreak in Taiwan
by: Min-Ru Lin, et al.
Published: (2024-09-01)

SARS coronavirus-2 omicron variant transmission fractional order model with respiratory-specific and vaccination effects
by: Taohua Liu, et al.
Published: (2025-08-01)

Omicron SARS-CoV-2 outcomes in vaccinated individuals with heart failure and ischaemic heart disease
by: Liang En Wee, et al.
Published: (2025-04-01)

Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2
by: Sumera Zaib, et al.
Published: (2022-11-01)

T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination
by: William C. McMahon, et al.
Published: (2025-06-01)

A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching
by: Jenny M. Lee, et al.
Published: (2025-03-01)

Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
by: Yu-An Kung, et al.
Published: (2025-07-01)

COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers
by: Leire Fernández-Ciriza, et al.
Published: (2025-01-01)

Emotional reactions towards vaccination during the emergence of the Omicron variant: Insights from twitter analysis in South Africa
by: Blessing Ogbuokiri, et al.
Published: (2025-06-01)

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
by: Kayvon Modjarrad, et al.
Published: (2024-11-01)

Critical COVID-19 in children and adolescents during the 2022 Omicron Surge in Taiwan: Risk factors and vaccine effectiveness
by: Jin-Yu Tsai, et al.
Published: (2025-06-01)

Impact of vaccination on Omicron's escape variants: Insights from fine-scale modelling of waning immunity in Hong Kong
by: Yuling Zou, et al.
Published: (2025-03-01)

Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
by: Ramandip Grewal, et al.
Published: (2024-12-01)

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
by: Camilo C. Roa, et al.
Published: (2024-12-01)

Dynamic monitoring of antibody titers in people living with HIV during Omicron epidemic: comparison between unvaccinated and vaccinated individuals
by: Shana Halemubieke, et al.
Published: (2025-07-01)

Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants
by: Busra Kaplan, et al.
Published: (2025-02-01)

COVID-19 vaccine effectiveness among healthcare workers during the Omicron period in the country of Georgia, January - June 2022.
by: Caleb L Ward, et al.
Published: (2025-01-01)

Author Correction: Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2
by: Sumera Zaib, et al.
Published: (2025-06-01)

Breaking misconceptions: a strategic communication model for promoting COVID-19 prevention through health protocols and vaccination in West Java Province, Indonesia
by: Uud Wahyudin, et al.
Published: (2025-12-01)

CD44 Variant Exon 6 Isoform Expression as a Potential Predictor of Lymph Node Metastasis in Invasive Breast Carcinoma of No Special Type
by: Primariadewi Rustamadji, et al.
Published: (2021-01-01)